Newron CEO On Xadago & Upcoming Pipeline Milestones
Executive Summary
Newron CEO Stefan Weber joins Scrip to discuss the company's recently approved Parkinson's therapy Xadago (safinamide), as well as development timelines for Newron's other pipeline candidates.